CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexander, F. E.
Right arrow Articles by Taylor, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexander, F. E.
Right arrow Articles by Taylor, G. M.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 705-709, June 2001
© 2001 American Association for Cancer Research


Short Communication

Epstein-Barr Virus and HLA-DPB1-*0301 in Young Adult Hodgkin’s Disease

Evidence for Inherited Susceptibility to Epstein-Barr Virus in Cases that Are EBV+ve

F. E. Alexander1, R. F. Jarrett, R. A. Cartwright, A. A. Armstrong, D. A. Gokhale, E. Kane, D. Gray, D. J. Lawrence and G. M. Taylor

Department of Community Health Sciences, University of Edinburgh Medical School, Edinburgh EH8 9AG [F. E. A.]; Leukaemia Research Fund Virus Centre, Department of Veterinary Pathology, Glasgow G61 1QH [R. F. J., A. A. A., D. G.]; Leukaemia Research Fund, Centre for Clinical Epidemiology, UMV Leeds, Leeds LS2 9NG [R. A. C., E. K.]; Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, Surrey SM2 5NG [D. A. G., D. J. L.]; and Immunogenetics Laboratory, University of Manchester, St. Mary’s Hospital, Manchester M13 0JH [G. M. T.], United Kingdom

Cases of Hodgkin’s disease (HD) may be distinguished by whether they do [EBV-positive (+ve) cases] or do not [EBV-negative (-ve) cases] have evidence of EBV DNA in the Reed-Sternberg cells. Only one study has attempted to distinguish epidemiological risk factors for EBV+ve and EBV-ve HD, and none have compared inherited susceptibility. The present study involves a population-based case series of HD, diagnosed in patients between 16–24 years of age in the United Kingdom (n = 118), of whom 87% were classified by EBV status (EBV+ve, 19, EBV-ve, 84). History of infectious illness, EBV antibody titers, and HLA-DPB1 type have been compared in EBV+ve and EBV-ve cases. Reported infectious mononucleosis was more frequent in EBV+ve cases (odds ratio (OR), 5.10; 95% confidence interval (CI), 1.12–24.4). EBV antibody titers to viral capsid antigen were significantly higher in EBV+ve cases (P for trend = 0.02). Higher proportions of EBV+ve (43%) than EBV-ve (31%) cases typed positive for HLA-DPB1*0301, but this was not statistically significant; the association of infectious mononucleosis with EBV+ve cases was stronger in this HLA subgroup (OR, 17.1; 95%CI, 1.06–1177) than in other cases (OR, 1.24; 95% CI, 0.02–15.4). Although these results are based on small numbers of HD cases, they provide suggestive evidence that the etiology of EBV+ve HD may involve inherited susceptibility to EBV.




This article has been cited by other articles:


Home page
haematolHome page
C. F. Skibola, J. D. Curry, and A. Nieters
Genetic susceptibility to lymphoma
Haematologica, July 1, 2007; 92(7): 960 - 969.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Hjalgrim, K. Ekstrom Smedby, K. Rostgaard, D. Molin, S. Hamilton-Dutoit, E. T. Chang, E. Ralfkiaer, C. Sundstrom, H.-O. Adami, B. Glimelius, et al.
Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma
Cancer Res., March 1, 2007; 67(5): 2382 - 2388.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
R F Jarrett, A S Krajewski, B Angus, J Freeland, P R Taylor, G M Taylor, and F E Alexander
The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates
J. Clin. Pathol., November 1, 2003; 56(11): 811 - 816.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. Hjalgrim, J. Askling, K. Rostgaard, S. Hamilton-Dutoit, M. Frisch, J.-S. Zhang, M. Madsen, N. Rosdahl, H. B. Konradsen, H. H. Storm, et al.
Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis
N. Engl. J. Med., October 2, 2003; 349(14): 1324 - 1332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.